Regardless, this review has identified HSD as a potential risk factor for the development of PGP, requiring a multidisciplinary approach to manage, provide adequate support, and appropriately diagnose rare conditions such as EDS. This evidence concerns the gene CHST3 and Ehlers-Danlos syndrome.